Seeing Is Believing
Currently out of the existing stock ratings of Jordan Abrams, 2 are a BUY (100%).
Analyst Jordan Abrams, Previously, Jordan Abrams worked at CANTOR FITZGERALD.
Jordan Abrams’s has documented 4 price targets and ratings displayed on 1 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on HTGM, HTG Molecular Diagnostics at 08-Apr-2019.
Analyst best performing recommendations are on HTGM (HTG MOLECULAR DIAGNOSTICS).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Mar-2020
$6
$5.65 (1614.29%)
$6
3 years 5 months 23 days ago
(19-Apr-2023)
1/3 (33.33%)
$2.85 (90.48%)
708
Buy Since 11-May-2020
$42
$41.65 (11900.00%)
$180
4 years 2 months 20 days ago
(22-Jul-2022)
0/4 (0%)
$30.34 (260.21%)
Buy
$3
$2.45 (445.45%)
$8
4 years 6 months 12 days ago
(30-Mar-2022)
1/6 (16.67%)
$1.21 (41.19%)
3
Buy Since 19-Apr-2017
7 years 1 months 29 days ago
(13-Aug-2019)
0/2 (0%)
$455.4 (56.60%)
Buy Since 20-Sep-2018
$1080
$1079.65 (308471.44%)
$1260
7 years 6 months 4 days ago
(08-Apr-2019)
0/2 (0%)
$626.4 (138.10%)